Quick Answer
INSMED Inc reported Operating Income Loss of -$1.25 billion for the year ending 2025.
- INSMED Inc showed a decrease of -42.0% in Operating Income Loss from 2024 to 2025.
- This data is from INSMED Inc's annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), INSMED Inc's Operating Income Loss has declined by 14,273.6%.
- Historical annual values: Fiscal year 2025: -$1.25 billion | Fiscal year 2024: -$878.25 million | Fiscal year 2023: -$709.63 million | Fiscal year 2022: -$457.32 million | Fiscal year 2021: -$375.09 million | Fiscal year 2020: -$265.23 million | Fiscal year 2019: -$235.25 million | Fiscal year 2018: -$307.34 million | Fiscal year 2017: -$188.92 million | Fiscal year 2016: -$173.40 million | Fiscal year 2015: -$117.49 million | Fiscal year 2014: -$87.37 million | Fiscal year 2013: -$55.02 million | Fiscal year 2012: -$42.44 million | Fiscal year 2011: -$61.72 million | Fiscal year 2010: -$8.09 million | Fiscal year 2009: -$8.67 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: